Delivery Order SPE2DB22D3009-SPE2DB24FAH96
Award Date 11/8/23
Potential Completion Date 11/9/23
Potential Value $7.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $32,741.42. The award provides for the delivery of 4,562,987,675 units of Ondansetron HCL 4 MG Tablets in 500-count packages to support military healthcare programs. This award does not have a set-aside designation, indicating open competition. The contract is...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,563,774,936 units of Ondansetron HCL 4 mg tablets. The award, valued at $2,928.70, is a delivery order with a firm fixed price. The contract does not have any set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver 4,561,783,106 units of Ondansetron ODT 4 mg tablets. The $4,427.20 firm-fixed-price delivery order has an ultimate completion date of August 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- The federal contract award SPE2DB20D3111|SPE2DB24FA7NU was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,953.32 firm fixed-price delivery order is for the supply of 4,564,478,692 Ondansetron ODT 4 mg tablets, with an ultimate completion date of May 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,562,954,458 units of Ondansetron HCL 4 mg tablets. The contract, valued at $4,013.25, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,564,558,882 units of Ondansetron HCl 4 mg tablets. The award, valued at $16,651.68, is a delivery order contract with a firm fixed price structure and a completion date of May 10, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $26,805.03, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract covers the delivery of 4,564,478,867 units of Ondansetron HCL 8 mg tablets to support military healthcare programs. The award is a firm-fixed-price delivery order contract with a completion date of May 3, 2024. This order is part of a larger...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,092.97 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary...
- This federal contract award, SPE2DB22D3016|SPE2DB24FAUA7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,451,499 units of Ondansetron HCL 4 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The contract has a ceiling value of $5,376.60 and a completion date of May 1, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $56,685.70 firm-fixed-price delivery order is for the supply of 500 units of Ondansetron HCL 4 mg tablets. The award has an ultimate completion date of February 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through...